Cargando…
Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
Remission of heart failure, defined by resolution of symptoms, normalization of left ventricular ejection fraction, and plasma concentrations of natriuretic peptides and by the ability to withdraw diuretic agents without recurrence of congestion is increasingly recognized among patients with dilated...
Autores principales: | Halliday, Brian P., Cleland, John G.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156436/ https://www.ncbi.nlm.nih.gov/pubmed/35663636 http://dx.doi.org/10.1016/j.jacbts.2022.03.008 |
Ejemplares similares
-
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2022) -
Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015) -
Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities
por: Smith, J. Gustav
Publicado: (2017) -
Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2021) -
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
por: Thomson, Kassandra S., et al.
Publicado: (2016)